Sanjeev Banerjee Selected Research

NF-kappa B (NF-kB)

1/2011	Garcinol-induced apoptosis in prostate and pancreatic cancer cells is mediated by NF- kappaB signaling.
5/2010	Concurrent inhibition of NF-kappaB, cyclooxygenase-2, and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancer.
4/2010	Apoptosis-inducing effect of garcinol is mediated by NF-kappaB signaling in breast cancer cells.
3/2010	Down-regulation of Notch-1 and Jagged-1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF-kappaB signaling pathways.
12/2009	Aging and inflammation: etiological culprits of cancer.
7/2009	Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer.
7/2009	3,3'-Diindolylmethane enhances chemosensitivity of multiple chemotherapeutic agents in pancreatic cancer.
5/2009	3,3'-Diindolylmethane enhances taxotere-induced apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation.
4/2009	Radiation-induced HIF-1alpha cell survival pathway is inhibited by soy isoflavones in prostate cancer cells.
1/2009	Curcumin synergizes with resveratrol to inhibit colon cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sanjeev Banerjee Research Topics

Disease

93	Neoplasms (Cancer) 01/2015 - 09/2002
53	Pancreatic Neoplasms (Pancreatic Cancer) 12/2015 - 05/2005
23	Prostatic Neoplasms (Prostate Cancer) 10/2013 - 12/2002
17	Neoplasm Metastasis (Metastasis) 05/2014 - 10/2005
16	Breast Neoplasms (Breast Cancer) 01/2016 - 09/2002
9	Carcinogenesis 01/2014 - 09/2002
8	Colonic Neoplasms (Colon Cancer) 11/2014 - 06/2007
5	Hypoxia (Hypoxemia) 12/2012 - 06/2007
3	Colorectal Neoplasms (Colorectal Cancer) 11/2014 - 02/2011
3	Inflammation (Inflammations) 10/2012 - 12/2009
3	Carcinoma (Carcinomatosis) 04/2009 - 03/2006
3	Lymphoma (Lymphomas) 09/2008 - 04/2007
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2015 - 01/2015
2	Triple Negative Breast Neoplasms 04/2013 - 12/2008
2	Chronic Disease (Chronic Diseases) 04/2011 - 12/2009
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 09/2008 - 04/2007
2	Lymphatic Metastasis 06/2007 - 03/2007
1	Brain Diseases (Brain Disorder) 01/2015
1	Arthritis (Polyarthritis) 01/2015
1	Osteoporosis 01/2015
1	Thrombosis (Thrombus) 01/2015
1	Cataract (Cataracts) 01/2015
1	Genomic Instability 01/2014

Drug/Important Bio-Agent (IBA)

35	NF-kappa B (NF-kB)IBA 01/2011 - 09/2002
24	Biological ProductsIBA 04/2013 - 11/2005
19	MicroRNAs (MicroRNA)IBA 01/2015 - 08/2009
17	CurcuminIBA 12/2015 - 12/2002
17	Proteins (Proteins, Gene)FDA Link 01/2014 - 12/2002
15	GenisteinIBA 01/2014 - 10/2005
14	Pharmaceutical PreparationsIBA 08/2015 - 08/2005
14	DNA (Deoxyribonucleic Acid)IBA 01/2014 - 11/2005
14	Gemcitabine FDA Link 05/2013 - 10/2005
13	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2013 - 03/2006
9	Cisplatin (Platino)FDA LinkGeneric 04/2013 - 08/2005
9	Transcription Factors (Transcription Factor)IBA 12/2012 - 06/2006
9	3,3'-diindolylmethane (diindolylmethane)IBA 01/2012 - 10/2006
8	IsoflavonesIBA 10/2013 - 10/2005
6	Matrix Metalloproteinases (MMPs)IBA 02/2013 - 03/2006
5	Platelet-Derived Growth FactorIBA 01/2016 - 12/2007
5	thymoquinoneIBA 05/2013 - 01/2008
5	garcinolIBA 02/2013 - 04/2010
5	ErbB Receptors (EGF Receptor)IBA 05/2010 - 05/2005
4	AntioxidantsIBA 01/2015 - 10/2008
4	Epithelial Cell Adhesion MoleculeIBA 08/2014 - 08/2011
4	Androgen Receptors (Androgen Receptor)IBA 05/2012 - 10/2006
4	Hormones (Hormone)IBA 05/2012 - 06/2006
4	AndrogensIBA 01/2012 - 10/2006
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2011 - 07/2009
4	Small Interfering RNA (siRNA)IBA 07/2010 - 03/2006
4	Complementary DNA (cDNA)IBA 07/2010 - 03/2006
4	SurvivinIBA 06/2010 - 05/2009
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2010 - 09/2002
4	LigandsIBA 03/2010 - 01/2006
3	3,4-difluorobenzylidenecurcuminIBA 12/2015 - 08/2015
3	ResveratrolIBA 04/2012 - 09/2002
3	Antineoplastic Agents (Antineoplastics)IBA 07/2011 - 10/2005
3	Jagged-1 ProteinIBA 03/2010 - 11/2006
3	Proteasome Endopeptidase Complex (Proteasome)IBA 08/2009 - 04/2007
3	Docetaxel (Taxotere)FDA Link 05/2009 - 04/2007
3	GossypolIBA 09/2008 - 11/2005
3	thiazolyl blueIBA 09/2007 - 03/2006
3	Cyclin D1IBA 05/2007 - 12/2002
3	matrigelIBA 04/2007 - 03/2006
3	Matrix Metalloproteinase 9 (Gelatinase B)IBA 08/2006 - 10/2005
2	Hyaluronic Acid (Hyaluronan)IBA 12/2015 - 09/2015
2	Dendrimers (Dendrons)IBA 12/2015 - 01/2015
2	LipidsIBA 01/2014 - 03/2008
2	daidzeinIBA 10/2013 - 03/2007
2	Chemokine ReceptorsIBA 04/2013 - 11/2006
2	CaspasesIBA 02/2013 - 01/2011
2	Metformin (Glucophage)FDA LinkGeneric 03/2012 - 04/2011
2	Interleukin-6 (Interleukin 6)IBA 01/2012 - 01/2012
2	Apoptosis Regulatory ProteinsIBA 01/2012 - 09/2008
2	indole-3-carbinolIBA 01/2012 - 11/2006
2	EnzymesIBA 07/2011 - 04/2010
2	PlatinumIBA 05/2011 - 11/2008
2	Histones (Histone)IBA 01/2011 - 04/2010
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 05/2010 - 06/2008
2	MI 319IBA 05/2010 - 04/2010
2	apogossypoloneIBA 04/2010 - 09/2008
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 11/2009 - 04/2007
2	Urokinase Plasminogen Activator ReceptorsIBA 11/2009 - 06/2009
2	CopperIBA 08/2009 - 06/2006
2	Estrogens (Estrogen)FDA Link 10/2008 - 04/2007
2	Therapeutic UsesIBA 10/2008 - 06/2007
2	Phosphotransferases (Kinase)IBA 11/2006 - 01/2006
1	Poly(amidoamine)IBA 12/2015
1	MicellesIBA 08/2015
1	Liposomes (Liposome)IBA 01/2015
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2015
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 11/2014
1	Eicosapentaenoic AcidIBA 11/2014
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 11/2014
1	SugarsIBA 01/2014

Therapy/Procedure

34	Therapeutics 12/2015 - 10/2005
11	Drug Therapy (Chemotherapy) 11/2014 - 08/2005
6	Radiotherapy 05/2014 - 03/2007
5	Chemoprevention 02/2011 - 09/2002
2	Oral Administration 03/2012 - 05/2010
1	Precision Medicine 01/2015